Clinical Investigation to Examine Toothpaste Effect on Oral Bacteria

Sponsor
Colgate Palmolive (Industry)
Overall Status
Completed
CT.gov ID
NCT02194621
Collaborator
(none)
128
1
3
1.9
66

Study Details

Study Description

Brief Summary

The primary objective was to evaluate the antibacterial effects of two toothpastes containing 0.3% triclosan, 2% copolymer and 0.234% sodium fluoride in a silica base as compared to a control regular fluoride toothpaste on anaerobic and malodor bacteria 12 hours after 13 days of product use. A secondary objective was to demonstrate that a toothpaste containing 0.3% triclosan, 2% copolymer, 0.234% sodium fluoride and a flavor with odor-masking ingredients in silica base (Colgate Total Toothpaste-Flavor Option 1) provides a level of antibacterial efficacy that is "equivalent" to a toothpaste containing 0.3% triclosan, 2% copolymer, 0.234% sodium fluoride and a regular flavor in silica base (Colgate Total Toothpaste-Flavor Option 2) after 13 days of product use.

Condition or Disease Intervention/Treatment Phase
  • Drug: Total Flavor option 1
  • Drug: Total Flavor option 2
  • Drug: Placebo toothpaste: Crest Cavity Protection toothpaste
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
128 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
A Randomized, Single Center, Three Cell, Double Blind and Parallel Groups Clinical Study Conducted in Newark, NJ to Evaluate the Antibacterial Effects of Two Toothpastes Containing 0.3% Triclosan/2% Copolymer/0.243% Sodium Fluoride in a Silica Base as Compared to a Control Regular Fluoride Toothpaste on Oral Bacteria 12 Hours After 13 Days Product Use.
Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Mar 1, 2014
Actual Study Completion Date :
Mar 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Total Flavor Option 1

Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM (oral malodor) complex 1 ingredient - Total Flavor Option 1

Drug: Total Flavor option 1
Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1
Other Names:
  • Total toothpaste
  • Experimental: Total Flavor Option 2

    Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM (oral malodor) complex 2 ingredient. Total Flavor Option 2

    Drug: Total Flavor option 2
    Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2
    Other Names:
  • Total toothpaste
  • Placebo Comparator: Crest Toothpaste

    Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed)

    Drug: Placebo toothpaste: Crest Cavity Protection toothpaste
    Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
    Other Names:
  • Crest Anti-Cavity toothpaste
  • Outcome Measures

    Primary Outcome Measures

    1. Anaerobic Bacteria [Baseline]

      Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units.

    2. Anaerobic Bacteria [12 hours]

      Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units.

    3. Malodor Bacteria (Breath Odor Causing Bacteria) [Baseline]

      Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units.

    4. Malodor Bacteria (Breath Odor Causing Bacteria) [12 hours]

      Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    22 Years to 58 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Males and females in good general health aged 18 to 70 years.

    2. A willingness to read, understand, and sign the Informed Consent Form after the nature of the study has been fully explained to them. Subject should demonstrate a willingness to comply with all study procedures and sampling schedules.

    3. A minimum of 20 natural teeth with facial and lingual scorable surfaces.

    4. Adequate oral hygiene and no signs of oral neglect.

    5. Good periodontal health. Enrolled subjects will have no more than five periodontal pockets of 5 mm.

    6. Subjects with gingival index greater than or equal to 1.0 (Loe-Silness Index) and plaque index greater than or equal to 1.5 (Turesky modification of Quigley-Hein Index) will be enrolled.

    Exclusion Criteria:
    1. History of significant adverse effects following use of oral hygiene products such as toothpastes and mouthrinses. Allergy to personal care/consumer products or their ingredients.

    2. Teeth that are grossly carious, fully crowned or extensively restored on facial and/or lingual surfaces, orthodontically banded, abutments, or third molars

    3. History of diabetes or hepatic or renal disease, or other serious medical conditions or transmittable diseases, e.g. heart disease or AIDS.

    4. History of rheumatic fever, heart murmur, mitral valve prolapse or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures.

    5. Subjects on antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.

    6. Significant oral soft tissue pathology, systemically related gingival enlargement, severe gingivitis (based on a visual examinations).

    7. History of active severe periodontal disease with bleeding gums and loose teeth.

    8. Gross dental caries, severe generalized cervical abrasion and/or enamel abrasion, large fractured or temporary restorations (based on visual examinations).will not be included in the tooth count.

    9. Fixed or removable orthodontic appliance or removable partial dentures.

    10. Participation in a dental plaque/gingivitis clinical study involving oral care products, within the last 30 days. History of dental prophylaxis or treatments in the past month.

    11. Self reported pregnancy or lactation.

    12. History or current use of objects to pierce the lips or tongue.

    13. Subjects known to be an alcoholic, or a recovering alcoholic.

    14. History or current use of recreational drugs.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rutgers School of Dental Medicine Newark New Jersey United States 07107

    Sponsors and Collaborators

    • Colgate Palmolive

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Colgate Palmolive
    ClinicalTrials.gov Identifier:
    NCT02194621
    Other Study ID Numbers:
    • CRO-1113-BACT-PS-NJ
    First Posted:
    Jul 18, 2014
    Last Update Posted:
    Apr 15, 2016
    Last Verified:
    Jul 1, 2014

    Study Results

    Participant Flow

    Recruitment Details subject recruitment is completed locally at the clinical site
    Pre-assignment Detail There will be a one (1) week wash out phase with commercially available fluoride toothpaste prior to any study intervention being assigned.
    Arm/Group Title Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Arm/Group Description Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
    Period Title: Overall Study
    STARTED 43 42 43
    COMPLETED 37 36 34
    NOT COMPLETED 6 6 9

    Baseline Characteristics

    Arm/Group Title Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste Total
    Arm/Group Description Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed) Total of all reporting groups
    Overall Participants 43 42 43 128
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    36.6
    (10.2)
    34.2
    (10.34)
    35.9
    (12.08)
    35.4
    (10.82)
    Sex: Female, Male (Count of Participants)
    Female
    28
    65.1%
    29
    69%
    24
    55.8%
    81
    63.3%
    Male
    15
    34.9%
    13
    31%
    19
    44.2%
    47
    36.7%
    Region of Enrollment (participants) [Number]
    United States
    43
    100%
    42
    100%
    43
    100%
    128
    100%

    Outcome Measures

    1. Primary Outcome
    Title Anaerobic Bacteria
    Description Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units.
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Arm/Group Description Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
    Measure Participants 43 42 43
    Mean (Standard Deviation) [colony forming units]
    8.40
    (0.33)
    8.42
    (0.25)
    8.43
    (0.28)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Total Flavor Option 1, Total Flavor Option 2, Crest Toothpaste
    Comments The null hypothesis states that there is no difference between groups.
    Type of Statistical Test Superiority or Other
    Comments
    Statistical Test of Hypothesis p-Value >0.05
    Comments
    Method ANOVA
    Comments
    2. Primary Outcome
    Title Anaerobic Bacteria
    Description Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units.
    Time Frame 12 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Arm/Group Description Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
    Measure Participants 37 36 34
    Mean (Standard Error) [colony forming units]
    7.68
    (0.09)
    7.71
    (0.09)
    8.37
    (0.09)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Total Flavor Option 2, Crest Toothpaste
    Comments The null hypothesis states that there is no difference between groups.
    Type of Statistical Test Superiority or Other
    Comments
    Statistical Test of Hypothesis p-Value <0.001
    Comments
    Method ANCOVA
    Comments
    3. Primary Outcome
    Title Malodor Bacteria (Breath Odor Causing Bacteria)
    Description Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units.
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Arm/Group Description Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
    Measure Participants 37 36 34
    Mean (Standard Deviation) [colony forming units]
    6.26
    (0.44)
    6.26
    (0.50)
    6.40
    (0.46)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Total Flavor Option 1, Total Flavor Option 2, Crest Toothpaste
    Comments The null hypothesis states that there is no difference between groups.
    Type of Statistical Test Superiority or Other
    Comments
    Statistical Test of Hypothesis p-Value >0.05
    Comments
    Method ANOVA
    Comments
    4. Primary Outcome
    Title Malodor Bacteria (Breath Odor Causing Bacteria)
    Description Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units.
    Time Frame 12 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Arm/Group Description Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
    Measure Participants 37 36 34
    Mean (Standard Error) [colony forming units]
    5.99
    (0.07)
    5.92
    (0.07)
    6.32
    (0.07)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Total Flavor Option 1, Total Flavor Option 2, Crest Toothpaste
    Comments The null hypothesis states that there is no difference between groups.
    Type of Statistical Test Superiority or Other
    Comments
    Statistical Test of Hypothesis p-Value 0.002
    Comments
    Method ANCOVA
    Comments

    Adverse Events

    Time Frame Baseline, 12 hours and 2 weeks
    Adverse Event Reporting Description
    Arm/Group Title Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Arm/Group Description Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
    All Cause Mortality
    Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN) / (NaN)
    Serious Adverse Events
    Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/43 (0%) 0/42 (0%) 0/43 (0%)
    Other (Not Including Serious) Adverse Events
    Total Flavor Option 1 Total Flavor Option 2 Crest Toothpaste
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/43 (0%) 0/42 (0%) 0/43 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.

    Results Point of Contact

    Name/Title Daniel Fine, DMD
    Organization RBHS-Rutgers School of Dental Medicine, Oral Biology Department
    Phone 973-972-3728
    Email finedh@sdm.rutgers.edu
    Responsible Party:
    Colgate Palmolive
    ClinicalTrials.gov Identifier:
    NCT02194621
    Other Study ID Numbers:
    • CRO-1113-BACT-PS-NJ
    First Posted:
    Jul 18, 2014
    Last Update Posted:
    Apr 15, 2016
    Last Verified:
    Jul 1, 2014